Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-11

FDA Approved: CABERGOLINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves a supplemental application for cabergoline from Ingenus Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)